Pages that link to "Q42802907"

The following pages link to Immunotherapy for sepsis--a new approach against an ancient foe. (Q42802907):

Displaying 50 items.

• Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action (Q21195823) (← links)
• Human recombinant activated protein C for severe sepsis (Q24201123) (← links)
• Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients (Q24202128) (← links)
• Human recombinant activated protein C for severe sepsis (Q24235181) (← links)
• Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species (Q24338871) (← links)
• Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression (Q24596423) (← links)
• The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use (Q24599103) (← links)
• Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review (Q26778888) (← links)
• Biomarkers for Sepsis: What Is and What Might Be? (Q26785255) (← links)
• Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies (Q26852697) (← links)
• Clinical review: sepsis and septic shock--the potential of gene arrays (Q26864138) (← links)
• Inhibition of intestinal epithelial apoptosis improves survival in a murine model of radiation combined injury (Q27304293) (← links)
• Park7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsis (Q28592872) (← links)
• Genomic responses in mouse models poorly mimic human inflammatory diseases (Q29547718) (← links)
• Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 (Q29615429) (← links)
• A robust scoring system to evaluate sepsis severity in an animal model. (Q30578164) (← links)
• Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome (Q33441000) (← links)
• Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock (Q33749935) (← links)
• Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis (Q33749945) (← links)
• The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial (Q33750231) (← links)
• B and T lymphocyte attenuator expression on CD4 T-cells associates with sepsis and subsequent infections in ICU patients (Q33753374) (← links)
• Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis (Q33753665) (← links)
• Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy (Q33828888) (← links)
• Sepsis-Associated Encephalopathy: Review of the Neuropsychiatric Manifestations and Cognitive Outcome (Q34031027) (← links)
• The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. (Q34057044) (← links)
• NAD -dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response. (Q34281758) (← links)
• New approaches to sepsis: molecular diagnostics and biomarkers. (Q34303687) (← links)
• SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome (Q34341386) (← links)
• Therapeutic interventions in sepsis: current and anticipated pharmacological agents (Q34427050) (← links)
• T-regulatory cells and programmed death 1 T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease (Q34480280) (← links)
• Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour? (Q34844755) (← links)
• Critical role of cRel subunit of NF-κB in sepsis survival (Q34931523) (← links)
• IFN-γ-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1. (Q34981423) (← links)
• The role of heat shock protein 70 in mediating age-dependent mortality in sepsis (Q35077846) (← links)
• Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients. (Q35100021) (← links)
• Clinical recovery from surgery correlates with single-cell immune signatures (Q35100326) (← links)
• The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis (Q35105870) (← links)
• Developing a clinically feasible personalized medicine approach to pediatric septic shock (Q35153451) (← links)
• Host responses to sepsis vary in different low-lethality murine models (Q35161494) (← links)
• Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependent (Q35175936) (← links)
• Validation of a gene expression-based subclassification strategy for pediatric septic shock. (Q35387550) (← links)
• Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. (Q35586397) (← links)
• Evidence-based translation for the genomic responses of murine models for the study of human immunity (Q35560983) (← links)
• The first step in utilizing immune-modulating therapies: immune status determination. (Q35567126) (← links)
• SIRT1 is a regulator in high glucose-induced inflammatory response in RAW264.7 cells (Q35582696) (← links)
• The CD14 rs2569190 TT Genotype Is Associated with an Improved 30-Day Survival in Patients with Sepsis: A Prospective Observational Cohort Study (Q35660734) (← links)
• Innate response activator B cells protect against microbial sepsis. (Q35757819) (← links)
• Comparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A. (Q35862009) (← links)
• Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release (Q35889143) (← links)
• Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions (Q35908002) (← links)